Richard Paul Bryce Puma Biotechnology, Inc. (PBYI) insider trading activity

Richard Paul Bryce is Officer of PUMA BIOTECHNOLOGY, INC.. Currently has a direct ownership of 121,662 shares of PBYI, which is worth approximately $341,870. The most recent transaction as insider was on Apr 05, 2021, when has been sold 426 shares (Common Stock) at a price of $9.8 per share, resulting in proceeds of $4,175. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 122K

0% 3M change

0% 12M change

Total Value Held $341,870

RICHARD PAUL BRYCE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 05 2021	SELL Open market or private sale	$4,175 $9.8 p/Share	426 Reduced 0.35%	121,662 Common Stock
Mar 02 2021	SELL Open market or private sale	$4,283 $10.15 p/Share	422 Reduced 0.34%	122,088 Common Stock
Feb 17 2021	BUY Grant, award, or other acquisition	-	52,846 Added 30.14%	122,510 Common Stock
Feb 02 2021	SELL Open market or private sale	$5,075 $12.23 p/Share	415 Reduced 0.59%	69,664 Common Stock
Jan 04 2021	SELL Open market or private sale	$66,986 $10.23 p/Share	6,548 Reduced 8.55%	70,079 Common Stock
Dec 02 2020	SELL Open market or private sale	$1,072 $11.65 p/Share	92 Reduced 0.12%	76,627 Common Stock
Nov 02 2020	SELL Open market or private sale	$758 $7.81 p/Share	97 Reduced 0.13%	76,719 Common Stock
Oct 02 2020	SELL Open market or private sale	$923 $10.14 p/Share	91 Reduced 0.12%	76,816 Common Stock

Also insider at

RAIN

Rain Therapeutics Inc. Healthcare

Chief Medical Officer

ENGN

enGene Holdings Inc.

Chief Medical Officer

RPB